Financials I had low expectations for this Q-report but it seems like PAT is about to turn around. Might take a hit in SP since the YoY comps are hard to beat (however shareholders know that last years rev is the ISC contract in 2020/BCIP contract in 2018/2019). Finally some rev from patscan platform, probably the Las Vegas casino deployment but could also possible be part of the signed contract in April. The 800k in backlog is a greatestvsign of a turnaround at least. Havnt checked the exact figure but Xtract was awarded around 1,5mil in May so i wonder if the 2,2mil contract commitment is the backlog + xtract, or more patscan platform orders + xtract in addition to the backlog. Time will tell.
I believe there will be dilution, the big question is when - my guess is somewhere in the fall of 2021. PE needs to stop the quite act, and publish NR for the coming contracts, else the SP will sit sub $1 and the raise will be horrific to current shareholders.